- Home
- JOF vs BWAY Comparison
JOF vs BWAY Comparison
Compare JOF & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOF
- BWAY
- Stock Information
- Founded
- JOF 1990
- BWAY 2003
- Country
- JOF Japan
- BWAY Israel
- Employees
- JOF N/A
- BWAY N/A
- Industry
- JOF Trusts Except Educational Religious and Charitable
- BWAY Medical/Dental Instruments
- Sector
- JOF Finance
- BWAY Health Care
- Exchange
- JOF Nasdaq
- BWAY Nasdaq
- Market Cap
- JOF 295.0M
- BWAY 280.7M
- IPO Year
- JOF N/A
- BWAY 2019
- Fundamental
- Price
- JOF $10.87
- BWAY $15.37
- Analyst Decision
- JOF
- BWAY Strong Buy
- Analyst Count
- JOF 0
- BWAY 2
- Target Price
- JOF N/A
- BWAY $18.00
- AVG Volume (30 Days)
- JOF 43.9K
- BWAY 79.0K
- Earning Date
- JOF 01-01-0001
- BWAY 11-11-2025
- Dividend Yield
- JOF 3.33%
- BWAY N/A
- EPS Growth
- JOF N/A
- BWAY 515.14
- EPS
- JOF N/A
- BWAY 0.11
- Revenue
- JOF N/A
- BWAY $46,084,000.00
- Revenue This Year
- JOF N/A
- BWAY $339.49
- Revenue Next Year
- JOF N/A
- BWAY $21.74
- P/E Ratio
- JOF N/A
- BWAY $54.58
- Revenue Growth
- JOF N/A
- BWAY 26.50
- 52 Week Low
- JOF $6.64
- BWAY $7.70
- 52 Week High
- JOF $8.04
- BWAY $16.25
- Technical
- Relative Strength Index (RSI)
- JOF 64.70
- BWAY 56.63
- Support Level
- JOF $10.78
- BWAY $15.32
- Resistance Level
- JOF $10.98
- BWAY $16.09
- Average True Range (ATR)
- JOF 0.11
- BWAY 0.64
- MACD
- JOF -0.01
- BWAY -0.12
- Stochastic Oscillator
- JOF 78.26
- BWAY 36.20
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.